The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non‐alcoholic fatty liver disease
- 12 May 2016
- journal article
- Published by Wiley in Liver International
- Vol. 36 (10), 1549-1557
- https://doi.org/10.1111/liv.13150
Abstract
Macrophage activation plays a key pathogenic role in experimental non-alcoholic fatty liver disease (NAFLD) and contributes to the progression of steatohepatitis (NASH) and fibrosis. We studied macrophage activation in human NAFLD by measuring soluble (s)CD163, a specific macrophage activation marker, hypothesizing that sCD163 would be associated with the patients' morphological disease grade. Further, we investigated an association between sCD163 and the apoptosis marker cytokeratin-18 (CK-18) to explore a link between macrophage activation and apoptosis.sCD163 associations with biochemical and histological measures of NAFLD were investigated in two independent cohorts of 157 Australian and 174 Italian NAFLD patients with liver biopsies graded for NAFLD severity, steatosis, and fibrosis. sCD163 and CK-18 were measured by ELISA.In both cohorts sCD163 increased in parallel with the patients' morphological disease grading, being independently associated with the Kleiner fibrosis score (p<0.001). A high sCD163 predicted advanced fibrosis (F≥3; Australian cohort: AUROC 0.77 (95% CI: 0.76-0.87), Italian cohort: 0.80 (95% CI: 0.72-0.88)). In both groups, sCD163 was independently associated with CK-18 (p<0.001).Soluble CD163 reflecting macrophage activation is associated with morphological features of NAFLD suggesting their involvement in the pathogenesis of NAFLD, NASH and particularly fibrosis. An independent association between sCD163 and cytokeratin-18 suggests that apoptosis may contribute to macrophage activation in NAFLD/NASH. This article is protected by copyright. All rights reserved.Funding Information
- National Health and Medical Research Council (1053206, 632630, 1049857)
- Seventh Framework Programme (HEALTH‐F2‐2009‐241762)
This publication has 39 references indexed in Scilit:
- Hepatic Macrophage Activation and the LPS Pathway in Patients With Alcoholic Hepatitis: A Prospective Cohort StudyThe American Journal of Gastroenterology, 2014
- Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and CJournal of Hepatology, 2014
- Macrophage heterogeneity in liver injury and fibrosisJournal of Hepatology, 2014
- Kuppfer Cells Trigger Nonalcoholic Steatohepatitis Development in Diet-induced Mouse Model through Tumor Necrosis Factor-α ProductionJournal of Biological Chemistry, 2012
- Kupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPSGut, 2011
- Kupffer cells in non-alcoholic fatty liver disease: The emerging viewJournal of Hepatology, 2009
- Pivotal Advance: Activation of cell surface Toll-like receptors causes shedding of the hemoglobin scavenger receptor CD163Journal of Leukocyte Biology, 2006
- Tumour necrosis factor signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in miceGut, 2006
- Plasma level of the macrophage‐derived soluble CD163 is increased and positively correlates with severity in Gaucher's diseaseEuropean Journal of Haematology, 2004
- CD163: a regulated hemoglobin scavenger receptor with a role in the anti‐inflammatory responseAnnals of Medicine, 2004